An 80-year-old man was diagnosed with iron deficiency anemia years ago.
Prospective cohorts are needed to evaluate the impact of recent strategies of early use of disease-modifying therapies and treat-to-target approach with immunomodulators and biologics.
Using an active comparator design to reduce bias, the researchers observed no increase in MI risk associated with starting a PPI versus starting a similar medication, histamine-2-receptor antagonists.
Urgent endoscopy was an independent predictor of lower mortality rate but was not associated with rebleeding in high-risk patients with acute nonvariceal UGIB.
A 12-year-old boy presented with a history of iron deficiency anemia for which he had taken oral iron supplementation for 2 years.
A 36-year-old woman with a history of thyroid goiter was found incidentally to have a hepatic tumor at a local clinic.